John Mignone MD, PhD reposted this
Through our partnership with JenaValve Technology, Inc., we're excited to announce new data from #TVT2023 uncovering that despite high two-year mortality rates and guideline indications for treatment, patients with severe AR received low rates of specialist evaluations and treatment with aortic valve replacement. https://ow.ly/7He750OKkWK
Partnership with egnite demonstrating real world evidence of 4 drug medical therapy plus device, over 20,000 patients. Three key points: 1. SGLT2i even stronger benefit in real world 2. ICD/CRT still show benefit in modern treatment. 3. Even in high performing institutions, <12% of patients are on the correct therapy. Using AI for patient care will identify and optimize care regardless of demographics and zip code. Full paper will be forthcoming. I look forward to see what medical system will truly start using data for AI based care.
The Swedish Advanced Cardiac Support ECMO Program has been awarded Gold Status by ELSO. This has been five years of extremely hard work and a multidisciplinary effort among Physicians, Nurses, APCs and Perfusionists. It was built on a vision after work, nights and weekends and I appreciate everyone’s strong contribution and personal motivation based on excellence.
